Literature DB >> 9321647

Vaccinia virion protein VP8, the 25 kDa product of the L4R gene, binds single-stranded DNA and RNA with similar affinity.

C D Bayliss1, G L Smith.   

Abstract

Vaccinia virus protein VP8 is a 25 kDa product of the L4R gene and is an abundant virion protein that binds single-stranded (ss) and double-stranded (ds) DNA. Binding of ssDNA is preferred at high salt concentrations. Using a recombinant 25 kDa L4R (rL4R) protein and a gel mobility shift assay with radiolabelled oligonucleotides, the Kd for a 45mer oligonucleotide was determined to be 2 nM. The Kd was unaltered by 50 mM KCl but was reduced 35-fold by 100 mM KCl. Multiple rL4R molecules bound to a single 45mer oligonucleotide, and using oligonucleotides of different lengths it was calculated that one rL4R molecule bound every 17 nt. Binding to ssDNA was competed by both deoxyribo- and ribo-polynucleotides. RNA binding was observed for both rL4R and native VP8, purified from virions, using a gel mobility shift with a radiolabelled ssRNA of 130 nt. The Kd of rL4R for this ssRNA substrate was 3 nM in the absence of salt and binding was positively cooperative. The potential roles of L4R protein in vaccinia virus early transcription are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9321647      PMCID: PMC147007          DOI: 10.1093/nar/25.20.3984

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  26 in total

1.  Stimulation of vaccinia virion DNA helicase I8R, but not A18R, by a vaccinia core protein L4R, an ssDNA binding protein.

Authors:  C D Bayliss; D Wilcock; G L Smith
Journal:  J Gen Virol       Date:  1996-11       Impact factor: 3.891

2.  Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion.

Authors:  K Essani; S Dales
Journal:  Virology       Date:  1979-06       Impact factor: 3.616

3.  Helix-destabilizing activity of phi 29 single-stranded DNA binding protein: effect on the elongation rate during strand displacement DNA replication.

Authors:  M S Soengas; C Gutiérrez; M Salas
Journal:  J Mol Biol       Date:  1995-11-03       Impact factor: 5.469

4.  Purification and properties of vaccinia virus DNA-dependent RNA polymerase.

Authors:  E Spencer; S Shuman; J Hurwitz
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

5.  Characterization of vaccinia polypeptides.

Authors:  M Oie; Y Ichihashi
Journal:  Virology       Date:  1981-08       Impact factor: 3.616

6.  Characterization of a polyriboadenylate polymerase from vaccinia virions.

Authors:  B Moss; E N Rosenblum; A Gershowitz
Journal:  J Biol Chem       Date:  1975-06-25       Impact factor: 5.157

7.  Vaccinia virions lacking the RNA helicase nucleoside triphosphate phosphohydrolase II are defective in early transcription.

Authors:  C H Gross; S Shuman
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

8.  Vaccinia virus gene A18R encodes an essential DNA helicase.

Authors:  D A Simpson; R C Condit
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Purification and characterization of a DNA-dependent RNA polymerase from vaccinia virions.

Authors:  B M Baroudy; B Moss
Journal:  J Biol Chem       Date:  1980-05-10       Impact factor: 5.157

10.  Vaccinia virions lacking core protein VP8 are deficient in early transcription.

Authors:  D Wilcock; G L Smith
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

View more
  10 in total

1.  Genome-wide analysis of vaccinia virus protein-protein interactions.

Authors:  S McCraith; T Holtzman; B Moss; S Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Activity, specificity, and probe design for the smallpox virus protease K7L.

Authors:  Alexander E Aleshin; Marcin Drag; Naran Gombosuren; Ge Wei; Jowita Mikolajczyk; Arnold C Satterthwait; Alex Y Strongin; Robert C Liddington; Guy S Salvesen
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

3.  Escherichia coli ribosomal protein L3 stimulates the helicase activity of the Bacillus stearothermophilus PcrA helicase.

Authors:  P Soultanas; M S Dillingham; D B Wigley
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

4.  Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.

Authors:  Christine Pugh; Sarah Keasey; Lawrence Korman; Phillip R Pittman; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2014-04-23

5.  Vaccinia virus mutations in the L4R gene encoding a virion structural protein produce abnormal mature particles lacking a nucleocapsid.

Authors:  Desyree Murta Jesus; Nissin Moussatche; Richard C Condit
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

6.  Microtubule-dependent organization of vaccinia virus core-derived early mRNAs into distinct cytoplasmic structures.

Authors:  M Mallardo; S Schleich; J Krijnse Locker
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

7.  Characterization of vaccinia virus intracellular cores: implications for viral uncoating and core structure.

Authors:  K Pedersen; E J Snijder; S Schleich; N Roos; G Griffiths; J K Locker
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

8.  Elucidating the essential role of the A14 phosphoprotein in vaccinia virus morphogenesis: construction and characterization of a tetracycline-inducible recombinant.

Authors:  P Traktman; K Liu; J DeMasi; R Rollins; S Jesty; B Unger
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  The vaccinia virus E8R gene product is required for formation of transcriptionally active virions.

Authors:  Sayuri E M Kato; Richard C Condit; Nissin Moussatché
Journal:  Virology       Date:  2007-07-09       Impact factor: 3.616

10.  The Vaccinia virion: Filling the gap between atomic and ultrastructure.

Authors:  Yeva Mirzakhanyan; Paul Gershon
Journal:  PLoS Pathog       Date:  2019-01-07       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.